BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2011
View Archived Issues
Pfizer claims novel agents for Gram-negative bacterial infections
Read More
Celecoxib may prevent lung cancer development/progression in former smokers
Read More
Metabolic Solutions Development begins phase II trial of MSDC-0160 in Alzheimer's disease
Read More
Final HORIZONS-AMI data favor bivalirudin and Taxus paclitaxel-eluting stent in STEMI
Read More
Evotec discloses new voltage-gated K(V)1.3 potassium channel blockers
Read More
Servier patents novel histamine H3 receptor antagonists
Read More
Novel GC-C agonists disclosed by Ironwood Pharmaceuticals
Read More
Everolimus improves response to trastuzumab in metastatic breast cancer
Read More
Celprogen's neuronal trans-differentiated stem cells show promise in models of Alzheimer's disease
Read More
Cardioxyl and Johns Hopkins University synthesize new nitroxyl donors
Read More
Aslan Pharmaceuticals licenses ARRY-543 from Array BioPharma
Read More
PU-H71 enters first-in-human phase I study in advanced malignancies
Read More
Lupus treatment Benlysta gains European marketing approval
Read More
Novel nNOS inhibitor displays potent analgesic effects in preclinical tests
Read More
Phase II trial shows aviscumine may improve survival in metastatic melanoma
Read More
OncoVista Innovative Therapies begins additional animal safety study of OVI-117
Read More
FDA's ODAC recommends accelerated approval of Adcetris for Hodgkin's lymphoma and ACLC
Read More
BioMarin's BMN-673 enters phase I trial in advanced hematological malignancies
Read More
Chugai seeks Japanese approval of Pulmozyme to improve pulmonary function in cystic fibrosis
Read More
Evolva completes phase I studies of EV-077
Read More
Vical and Astellas Pharma enter worldwide license agreements for TransVax cytomegalovirus vaccine
Read More
Pertuzumab/trastuzumab/docetaxel improves progression-free survival in HER2+ breast cancer
Read More
Development of Impax's IPX-066 for Parkinson's disease supported by Michael J. Fox Foundation grant
Read More
Biotec Pharmacon reports phase I/II data on SBG/3F8 combination in pediatric neuroblastoma
Read More
FDA issues complete response letter for resubmitted Intermezzo NDA
Read More